core molding - CMT
CMT
Close Chg Chg %
20.05 -0.80 -3.97%
Closed Market
19.26
-0.80 (3.97%)
Volume: 40.49K
Last Updated:
Jan 2, 2026, 3:59 PM EDT
Company Overview: core molding - CMT
CMT Key Data
| Open $20.13 | Day Range 19.22 - 20.13 |
| 52 Week Range 12.25 - 22.29 | Market Cap $171.66M |
| Shares Outstanding 8.56M | Public Float 7.78M |
| Beta 0.46 | Rev. Per Employee N/A |
| P/E Ratio 21.58 | EPS $0.94 |
| Yield 0.00% | Dividend $0.05 |
| EX-DIVIDEND DATE May 21, 2018 | SHORT INTEREST N/A |
| AVERAGE VOLUME 26.82K |
CMT Performance
| 1 Week | -8.55% | ||
| 1 Month | 3.79% | ||
| 3 Months | 3.07% | ||
| 1 Year | 23.71% | ||
| 5 Years | 42.04% |
CMT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
About core molding - CMT
Core Molding Technologies, Inc. is an engineered materials company specializing in molded thermoplastic and thermoset structural products, principally in building products, utilities, transportation and powersports industries across North America. The company offers compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics and structural foam and structural web injection molding. The company was founded in 1996 and is headquartered in Columbus, OH.
CMT At a Glance
Core Molding Technologies, Inc.
800 Manor Park Drive
Columbus, Ohio 43228-0183
| Phone | 1-614-870-5000 | Revenue | 302.38M | |
| Industry | Industrial Machinery | Net Income | 13.30M | |
| Sector | Producer Manufacturing | Employees | 1,570 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
CMT Valuation
| P/E Current | 21.578 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 10.928 |
| Price to Sales Ratio | 0.481 |
| Price to Book Ratio | 0.967 |
| Price to Cash Flow Ratio | 4.13 |
| Enterprise Value to EBITDA | 3.991 |
| Enterprise Value to Sales | 0.421 |
| Total Debt to Enterprise Value | 0.186 |
CMT Efficiency
| Revenue/Employee | 192,597.452 |
| Income Per Employee | 8,470.701 |
| Receivables Turnover | 8.231 |
| Total Asset Turnover | 1.43 |
CMT Liquidity
| Current Ratio | 2.803 |
| Quick Ratio | 2.303 |
| Cash Ratio | 1.139 |
CMT Profitability
| Gross Margin | 17.846 |
| Operating Margin | 6.137 |
| Pretax Margin | 5.781 |
| Net Margin | 4.398 |
| Return on Assets | 6.289 |
| Return on Equity | 9.29 |
| Return on Total Capital | 7.775 |
| Return on Invested Capital | 8.051 |
CMT Capital Structure
| Total Debt to Total Equity | 16.08 |
| Total Debt to Total Capital | 13.852 |
| Total Debt to Total Assets | 11.308 |
| Long-Term Debt to Equity | 14.049 |
| Long-Term Debt to Total Capital | 12.103 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Core Molding - CMT
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 307.48M | 377.38M | 357.74M | 302.38M | |
Sales Growth
| +38.28% | +22.73% | -5.20% | -15.48% | |
Cost of Goods Sold (COGS) incl D&A
| 266.14M | 324.98M | 295.44M | 248.41M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 11.62M | 11.88M | 12.83M | 13.32M | |
Depreciation
| 9.18M | 9.65M | 11.23M | 11.73M | |
Amortization of Intangibles
| 1.95M | 1.95M | 1.60M | 1.59M | |
COGS Growth
| +41.26% | +22.11% | -9.09% | -15.92% | |
Gross Income
| 41.34M | 52.40M | 62.30M | 53.96M | |
Gross Income Growth
| +21.79% | +26.74% | +18.89% | -13.38% | |
Gross Profit Margin
| +13.45% | +13.89% | +17.41% | +17.85% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 27.84M | 34.80M | 37.69M | 35.41M | |
Research & Development
| 1.30M | 1.60M | 1.70M | 1.90M | |
Other SG&A
| 26.54M | 33.20M | 35.99M | 33.51M | |
SGA Growth
| +14.27% | +24.98% | +8.31% | -6.06% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 2.58M | 1.58M | - |
EBIT after Unusual Expense
| 10.92M | 16.02M | 24.60M | 18.56M | |
Non Operating Income/Expense
| 311.00K | 533.00K | 2.64M | 682.00K | |
Non-Operating Interest Income
| - | - | - | 1.44M | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 2.31M | 1.97M | 1.49M | 1.76M | |
Interest Expense Growth
| -46.29% | -14.97% | -23.97% | +17.67% | |
Gross Interest Expense
| 2.31M | 1.97M | 1.49M | 1.76M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 8.92M | 14.59M | 25.75M | 17.48M | |
Pretax Income Growth
| +96.15% | +63.53% | +76.52% | -32.10% | |
Pretax Margin
| +2.90% | +3.86% | +7.20% | +5.78% | |
Income Tax
| 4.25M | 2.38M | 5.42M | 4.18M | |
Income Tax - Current - Domestic
| (364.00K) | (45.00K) | 114.00K | 1.90M | |
Income Tax - Current - Foreign
| 4.98M | 5.90M | 2.83M | 1.80M | |
Income Tax - Deferred - Domestic
| (200.00K) | (3.55M) | 2.92M | 879.00K | |
Income Tax - Deferred - Foreign
| (167.00K) | 80.00K | (451.00K) | (406.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | (232.00K) | (180.00K) | (81.00K) | |
Consolidated Net Income
| 4.44M | 12.02M | 20.24M | 13.30M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 4.44M | 12.02M | 20.24M | 13.30M | |
Net Income Growth
| -42.66% | +170.85% | +68.37% | -34.30% | |
Net Margin Growth
| +1.44% | +3.19% | +5.66% | +4.40% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 4.44M | 12.02M | 20.24M | 13.30M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 4.44M | 12.02M | 20.24M | 13.30M | |
EPS (Basic)
| 0.5506 | 1.4388 | 2.3676 | 1.5298 | |
EPS (Basic) Growth
| -43.55% | +161.31% | +64.55% | -35.39% | |
Basic Shares Outstanding
| 8.06M | 8.36M | 8.55M | 8.69M | |
EPS (Diluted)
| 0.5506 | 1.4368 | 2.3077 | 1.5135 | |
EPS (Diluted) Growth
| -43.53% | +160.95% | +60.61% | -34.42% | |
Diluted Shares Outstanding
| 8.06M | 8.37M | 8.77M | 8.79M | |
EBITDA
| 25.12M | 29.48M | 37.43M | 31.88M | |
EBITDA Growth
| +18.23% | +17.39% | +26.97% | -14.85% | |
EBITDA Margin
| +8.17% | +7.81% | +10.46% | +10.54% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 22.00 | |
| Number of Ratings | 1 | Current Quarters Estimate | 0.30 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 1.68 | |
| Last Quarter’s Earnings | 0.23 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.16 | Next Fiscal Year Estimate | N/A | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 1 | N/A |
| Mean Estimate | 0.30 | 0.47 | 1.68 | N/A |
| High Estimates | 0.30 | 0.47 | 1.68 | N/A |
| Low Estimate | 0.30 | 0.47 | 1.68 | N/A |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Core Molding - CMT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Core Molding - CMT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 28, 2025 | Thomas R. Cellitti Director | 99,268 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.89 per share | 1,875,172.52 |
| Aug 28, 2025 | Thomas R. Cellitti Director | 96,165 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.64 per share | 1,792,515.60 |
| Aug 13, 2025 | Alex J. Panda EVP, Treasurer, Secretary, CFO | 29,596 | Open market or private purchase of non-derivative security Non-derivative transaction at $17.06 per share | 504,907.76 |
| Apr 4, 2025 | John P. Zimmer EVP, Treasurer, Secretary, CFO | 92,971 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.63 per share | 1,267,194.73 |
| Apr 4, 2025 | John P. Zimmer EVP, Treasurer, Secretary, CFO | 91,114 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.52 per share | 1,231,861.28 |
| Mar 21, 2025 | Eric L. Palomaki EVP,Operations | 159,244 | Open market or private purchase of non-derivative security Non-derivative transaction at $14.01 per share | 2,231,008.44 |
| Mar 21, 2025 | Eric L. Palomaki EVP,Operations | 160,244 | Open market or private purchase of non-derivative security Non-derivative transaction at $13.99 per share | 2,241,813.56 |
| Mar 17, 2025 | Ralph O. Hellmold Director | 33,590 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 430,287.90 |
| Mar 17, 2025 | Matthew E. Jauchius Director | 57,542 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 737,113.02 |
| Mar 17, 2025 | Salvador Miñarro Villalobos Director | 10,256 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 131,379.36 |
| Mar 17, 2025 | Andrew O. Smith Director | 96,490 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 1,236,036.90 |
| Mar 17, 2025 | David L. Duvall Chief Executive Officer; Director | 298,249 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 3,820,569.69 |
| Mar 17, 2025 | David L. Duvall Chief Executive Officer; Director | 292,560 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.52 per share | 3,955,411.20 |
| Mar 17, 2025 | David L. Duvall Chief Executive Officer; Director | 288,543 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.62 per share | 3,929,955.66 |
| Mar 17, 2025 | Sandra L. Kowaleski Director | 30,635 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $12.81 per share | 392,434.35 |